These adjustments seem to improve the peptide's pharmacokinetic properties
J.de BruijnE
In 2024, Wegovy also received FDA approval to reduce the risk of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in adults with established cardiovascular disease and either obesity or overweight
Studies show this creates a purinergic signaling cascade that drives vascular repair [1]
Gut health responds fastest: Patients with SIBO residual symptoms, chronic GI distress, or post-antibiotic gut damage typically report meaningful improvement in GI symptoms within the first 30 days
Hill made a YouTube video about her journey with weight-loss drugs in May 2025, titled "I TRIED A GLP-1 FOR 3 MONTHS." In the video, she visited Luminous Medical Aesthetics in Woodland Hills, California, and explained that the doctor was to perform an ultrasound of the area around her mouth